Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 35 | 2024 | 280 | 8.220 |
Why?
|
| Sleep | 31 | 2024 | 313 | 7.170 |
Why?
|
| Melatonin | 21 | 2023 | 94 | 4.590 |
Why?
|
| Light | 13 | 2023 | 76 | 3.080 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 12 | 2021 | 39 | 2.440 |
Why?
|
| Adolescent | 26 | 2024 | 2279 | 1.620 |
Why?
|
| Work Schedule Tolerance | 4 | 2018 | 39 | 1.590 |
Why?
|
| Biological Clocks | 4 | 2018 | 16 | 1.580 |
Why?
|
| Schools | 5 | 2022 | 43 | 1.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2020 | 200 | 1.440 |
Why?
|
| Wakefulness | 5 | 2017 | 81 | 1.430 |
Why?
|
| Circadian Clocks | 4 | 2020 | 31 | 1.380 |
Why?
|
| Blood Glucose | 5 | 2017 | 112 | 1.330 |
Why?
|
| Seasons | 6 | 2021 | 31 | 1.230 |
Why?
|
| Adolescent Development | 2 | 2018 | 5 | 1.070 |
Why?
|
| Female | 40 | 2024 | 16197 | 1.010 |
Why?
|
| Saliva | 9 | 2015 | 53 | 0.990 |
Why?
|
| Humans | 57 | 2024 | 29337 | 0.990 |
Why?
|
| Puberty | 2 | 2015 | 10 | 0.960 |
Why?
|
| Adolescent Behavior | 2 | 2018 | 29 | 0.930 |
Why?
|
| Male | 36 | 2024 | 15621 | 0.910 |
Why?
|
| Interleukin-2 | 2 | 2020 | 66 | 0.900 |
Why?
|
| Homeostasis | 4 | 2018 | 82 | 0.860 |
Why?
|
| Time Factors | 14 | 2020 | 1616 | 0.840 |
Why?
|
| Sex Characteristics | 3 | 2017 | 132 | 0.800 |
Why?
|
| Adult | 25 | 2022 | 8601 | 0.790 |
Why?
|
| Single-Domain Antibodies | 1 | 2020 | 1 | 0.750 |
Why?
|
| Melanoma | 2 | 2020 | 52 | 0.740 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 13 | 0.740 |
Why?
|
| Sleep Wake Disorders | 5 | 2024 | 148 | 0.730 |
Why?
|
| Photoperiod | 4 | 2017 | 43 | 0.720 |
Why?
|
| Peptides | 1 | 2020 | 95 | 0.690 |
Why?
|
| Child | 14 | 2024 | 1346 | 0.660 |
Why?
|
| Students | 3 | 2019 | 37 | 0.630 |
Why?
|
| Entorhinal Cortex | 1 | 2017 | 37 | 0.620 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 81 | 0.600 |
Why?
|
| Neuroimaging | 1 | 2017 | 136 | 0.580 |
Why?
|
| Feeding Behavior | 2 | 2014 | 100 | 0.570 |
Why?
|
| Models, Neurological | 1 | 2015 | 30 | 0.550 |
Why?
|
| Depression | 4 | 2017 | 465 | 0.550 |
Why?
|
| Specimen Handling | 1 | 2015 | 48 | 0.540 |
Why?
|
| Jet Lag Syndrome | 5 | 2022 | 16 | 0.530 |
Why?
|
| Surveys and Questionnaires | 11 | 2021 | 1184 | 0.520 |
Why?
|
| Occupational Health | 1 | 2014 | 21 | 0.510 |
Why?
|
| Feeding and Eating Disorders | 1 | 2014 | 12 | 0.490 |
Why?
|
| Young Adult | 8 | 2021 | 1932 | 0.490 |
Why?
|
| Affect | 1 | 2014 | 64 | 0.480 |
Why?
|
| Actigraphy | 4 | 2014 | 98 | 0.470 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1221 | 0.450 |
Why?
|
| Sleep Stages | 1 | 2012 | 34 | 0.440 |
Why?
|
| Middle Aged | 13 | 2021 | 9823 | 0.420 |
Why?
|
| Child Development | 1 | 2011 | 71 | 0.390 |
Why?
|
| Body Weight | 2 | 2019 | 133 | 0.340 |
Why?
|
| Aging | 2 | 2015 | 1593 | 0.340 |
Why?
|
| Pediatric Obesity | 2 | 2019 | 44 | 0.340 |
Why?
|
| Parkinson Disease | 1 | 2017 | 1164 | 0.330 |
Why?
|
| Dental Caries | 4 | 2000 | 5 | 0.320 |
Why?
|
| Child, Preschool | 4 | 2024 | 642 | 0.320 |
Why?
|
| Mice | 6 | 2023 | 1607 | 0.300 |
Why?
|
| Neoplasms | 2 | 2021 | 247 | 0.290 |
Why?
|
| NF-kappa B | 2 | 2023 | 107 | 0.270 |
Why?
|
| Aged | 8 | 2020 | 9448 | 0.270 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 264 | 0.260 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2023 | 4 | 0.260 |
Why?
|
| Darkness | 2 | 2005 | 18 | 0.260 |
Why?
|
| Mood Disorders | 1 | 2004 | 31 | 0.250 |
Why?
|
| Arousal | 1 | 2004 | 42 | 0.250 |
Why?
|
| Clothing | 1 | 2003 | 4 | 0.240 |
Why?
|
| Phototherapy | 3 | 2013 | 37 | 0.240 |
Why?
|
| Dermatitis, Atopic | 1 | 2024 | 19 | 0.240 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 211 | 0.240 |
Why?
|
| Immunotherapy | 2 | 2021 | 62 | 0.240 |
Why?
|
| Preventive Dentistry | 2 | 2000 | 2 | 0.230 |
Why?
|
| Time Management | 1 | 2023 | 5 | 0.230 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 1 | 0.230 |
Why?
|
| Animals | 6 | 2023 | 4552 | 0.220 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 55 | 0.220 |
Why?
|
| Body Mass Index | 5 | 2021 | 428 | 0.210 |
Why?
|
| Universities | 1 | 2022 | 35 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 142 | 0.210 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 129 | 0.210 |
Why?
|
| Public Health Dentistry | 2 | 2000 | 2 | 0.210 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 55 | 0.200 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 5 | 0.200 |
Why?
|
| Phagocytes | 1 | 2021 | 23 | 0.200 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 19 | 0.200 |
Why?
|
| Bacteria | 1 | 2021 | 77 | 0.200 |
Why?
|
| Photic Stimulation | 2 | 2015 | 44 | 0.200 |
Why?
|
| Weight Gain | 1 | 2021 | 66 | 0.190 |
Why?
|
| Models, Economic | 1 | 2000 | 9 | 0.190 |
Why?
|
| Lamivudine | 1 | 2000 | 18 | 0.190 |
Why?
|
| Hepatitis B, Chronic | 1 | 2000 | 6 | 0.190 |
Why?
|
| Camelids, New World | 1 | 2020 | 1 | 0.190 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 2 | 0.190 |
Why?
|
| Adie Syndrome | 1 | 2020 | 1 | 0.190 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 3 | 0.190 |
Why?
|
| Cognition | 2 | 2019 | 1277 | 0.190 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 5 | 0.190 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 10 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 24 | 0.190 |
Why?
|
| Drug Synergism | 1 | 2020 | 63 | 0.190 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 37 | 0.190 |
Why?
|
| Autoantigens | 1 | 2020 | 36 | 0.180 |
Why?
|
| Body Height | 1 | 2019 | 33 | 0.180 |
Why?
|
| Leukoaraiosis | 1 | 2019 | 6 | 0.180 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2019 | 1 | 0.180 |
Why?
|
| Peyer's Patches | 1 | 2019 | 2 | 0.180 |
Why?
|
| Natural Killer T-Cells | 1 | 2019 | 5 | 0.180 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 251 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 66 | 0.180 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 4 | 0.170 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Interleukin-15 | 1 | 2019 | 11 | 0.170 |
Why?
|
| Drug Design | 1 | 2019 | 30 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 180 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2000 | 132 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 170 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 153 | 0.170 |
Why?
|
| Immunoglobulin Fragments | 1 | 2018 | 1 | 0.160 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2018 | 9 | 0.160 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 6 | 0.160 |
Why?
|
| Wechsler Memory Scale | 1 | 2017 | 1 | 0.160 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 216 | 0.160 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 4 | 0.150 |
Why?
|
| Software | 1 | 2017 | 72 | 0.150 |
Why?
|
| Human Migration | 1 | 2017 | 2 | 0.150 |
Why?
|
| Africa | 1 | 2017 | 10 | 0.150 |
Why?
|
| United States | 3 | 2021 | 2333 | 0.150 |
Why?
|
| Europe | 1 | 2017 | 81 | 0.150 |
Why?
|
| Sleep-Wake Transition Disorders | 1 | 2015 | 1 | 0.140 |
Why?
|
| Cariostatic Agents | 4 | 2000 | 4 | 0.140 |
Why?
|
| Preoptic Area | 1 | 2015 | 6 | 0.140 |
Why?
|
| Glycemic Index | 1 | 2015 | 3 | 0.140 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 15 | 0.140 |
Why?
|
| Thailand | 1 | 2015 | 11 | 0.140 |
Why?
|
| Neural Inhibition | 1 | 2015 | 10 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 788 | 0.140 |
Why?
|
| Sexual Maturation | 1 | 2015 | 2 | 0.140 |
Why?
|
| Nerve Net | 1 | 2015 | 54 | 0.130 |
Why?
|
| Fluorides | 3 | 2000 | 3 | 0.130 |
Why?
|
| Occupations | 1 | 2014 | 15 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 2 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2022 | 482 | 0.120 |
Why?
|
| Syndrome | 1 | 2014 | 82 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2013 | 7 | 0.120 |
Why?
|
| Breakfast | 1 | 2013 | 1 | 0.120 |
Why?
|
| Eating | 1 | 2014 | 45 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 959 | 0.120 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 24 | 0.120 |
Why?
|
| Psychotherapy | 1 | 2013 | 34 | 0.120 |
Why?
|
| Age Factors | 2 | 2017 | 843 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2014 | 187 | 0.110 |
Why?
|
| Algorithms | 1 | 2015 | 400 | 0.110 |
Why?
|
| Pit and Fissure Sealants | 4 | 2000 | 4 | 0.110 |
Why?
|
| Neurons | 1 | 2015 | 374 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 4 | 2000 | 144 | 0.110 |
Why?
|
| Prevalence | 1 | 2014 | 487 | 0.110 |
Why?
|
| Jamaica | 2 | 2021 | 2 | 0.100 |
Why?
|
| Ghana | 2 | 2021 | 4 | 0.100 |
Why?
|
| South Africa | 2 | 2021 | 17 | 0.100 |
Why?
|
| Energy Intake | 3 | 2017 | 66 | 0.090 |
Why?
|
| Random Allocation | 1 | 2010 | 146 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1442 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2021 | 1939 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3273 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2020 | 676 | 0.080 |
Why?
|
| DMF Index | 4 | 2000 | 4 | 0.080 |
Why?
|
| Victoria | 4 | 2000 | 6 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1251 | 0.080 |
Why?
|
| Health Status | 1 | 2007 | 227 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 724 | 0.070 |
Why?
|
| Aviation | 1 | 2005 | 4 | 0.070 |
Why?
|
| Work | 1 | 2005 | 10 | 0.070 |
Why?
|
| Program Evaluation | 3 | 2000 | 132 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2004 | 15 | 0.060 |
Why?
|
| Body Temperature | 1 | 2004 | 58 | 0.060 |
Why?
|
| Mental Recall | 1 | 2004 | 74 | 0.060 |
Why?
|
| Mouthwashes | 3 | 1998 | 6 | 0.060 |
Why?
|
| Diet | 2 | 2017 | 174 | 0.060 |
Why?
|
| Rest | 1 | 2024 | 32 | 0.060 |
Why?
|
| Lighting | 1 | 2003 | 16 | 0.060 |
Why?
|
| School Dentistry | 2 | 2000 | 2 | 0.060 |
Why?
|
| Immunity | 1 | 2023 | 24 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2003 | 3 | 0.060 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2022 | 3 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2004 | 174 | 0.060 |
Why?
|
| DNA Damage | 1 | 2022 | 30 | 0.060 |
Why?
|
| Depression, Postpartum | 1 | 2003 | 16 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 81 | 0.050 |
Why?
|
| Apoptosis | 1 | 2023 | 251 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 56 | 0.050 |
Why?
|
| Inflammation | 1 | 2024 | 344 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 73 | 0.050 |
Why?
|
| Feces | 1 | 2021 | 98 | 0.050 |
Why?
|
| Meals | 1 | 2021 | 12 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2021 | 109 | 0.050 |
Why?
|
| Regional Health Planning | 1 | 2000 | 4 | 0.050 |
Why?
|
| Rural Health Services | 1 | 2000 | 3 | 0.050 |
Why?
|
| Adolescent Health Services | 1 | 2000 | 6 | 0.050 |
Why?
|
| Seychelles | 1 | 2020 | 1 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2021 | 73 | 0.050 |
Why?
|
| Mothers | 1 | 2003 | 178 | 0.050 |
Why?
|
| Macrophages | 1 | 2021 | 128 | 0.050 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 2 | 0.050 |
Why?
|
| Time | 1 | 2019 | 18 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1113 | 0.050 |
Why?
|
| Epidemics | 1 | 2019 | 4 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2020 | 43 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2000 | 66 | 0.050 |
Why?
|
| Galactosylceramides | 1 | 2019 | 1 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2019 | 1 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 2 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Public Health | 1 | 2019 | 60 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2019 | 81 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 58 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 41 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 14 | 0.040 |
Why?
|
| Protein Stability | 1 | 2019 | 7 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 7 | 0.040 |
Why?
|
| Self Report | 1 | 2020 | 218 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 71 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2019 | 146 | 0.040 |
Why?
|
| Executive Function | 1 | 2019 | 121 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 193 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2019 | 81 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 66 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 219 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 10 | 0.040 |
Why?
|
| Alkenes | 1 | 1998 | 1 | 0.040 |
Why?
|
| Metalloporphyrins | 1 | 1998 | 2 | 0.040 |
Why?
|
| Epoxy Compounds | 1 | 1998 | 6 | 0.040 |
Why?
|
| Incidence | 1 | 2000 | 756 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 218 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 1011 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 260 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 432 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 2443 | 0.040 |
Why?
|
| Linear Models | 1 | 2013 | 254 | 0.030 |
Why?
|
| Insulin | 1 | 2013 | 92 | 0.030 |
Why?
|
| Health Education, Dental | 2 | 1998 | 2 | 0.020 |
Why?
|
| Fluoridation | 2 | 1998 | 2 | 0.020 |
Why?
|
| Oral Hygiene | 2 | 1998 | 6 | 0.020 |
Why?
|
| MMPI | 1 | 2005 | 8 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 38 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 77 | 0.020 |
Why?
|
| Personality | 1 | 2005 | 68 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 4851 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 52 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 403 | 0.010 |
Why?
|
| Dental Caries Susceptibility | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1998 | 1 | 0.010 |
Why?
|
| World Health Organization | 1 | 1998 | 18 | 0.010 |
Why?
|
| Observer Variation | 1 | 1998 | 118 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 145 | 0.010 |
Why?
|
| Dental Auxiliaries | 1 | 1998 | 1 | 0.010 |
Why?
|
| Dental Care for Children | 1 | 1998 | 1 | 0.010 |
Why?
|
| Dentists | 1 | 1998 | 2 | 0.010 |
Why?
|
| Water Supply | 1 | 1998 | 3 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1998 | 3 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 10 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 13 | 0.010 |
Why?
|
| Copper | 1 | 1998 | 9 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 14 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1998 | 15 | 0.010 |
Why?
|
| Dental Health Services | 1 | 1997 | 1 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1998 | 12 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 321 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 56 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 42 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 1997 | 15 | 0.010 |
Why?
|
| Cost Savings | 1 | 1998 | 36 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 1997 | 28 | 0.010 |
Why?
|
| Health Resources | 1 | 1998 | 24 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 1997 | 20 | 0.010 |
Why?
|
| Health Policy | 1 | 1998 | 50 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 81 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1997 | 101 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1997 | 148 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1997 | 138 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 1830 | 0.010 |
Why?
|